Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lyell's syndrome.

Adone Baroni1, Eleonora Ruocco

  • 1Department of Dermatology, Second University of Naples, Naples, Italy. adonebaroni@virgilio.it

Skinmed
|July 15, 2005
PubMed
Summary
This summary is machine-generated.

Toxic epidermal necrolysis (Lyell's syndrome) is a severe drug-induced skin reaction. High-dose intravenous immunoglobulins show promise as a novel and effective treatment for this life-threatening condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Web-based family-reported outcomes to assess family functioning in multiple sclerosis: an Italian multicenter digital survey.

International journal of medical informatics·2026
Same author

Assessment on effectiveness and safety of plasma radiofrequency ablation in facial and eye rejuvenation: a preliminary retrospective study.

Dermatology reports·2026
Same author

The Role of Zinc in Pediatric Asthma and Allergic Rhinitis: Mechanisms and Clinical Implications.

Nutrients·2025
Same author

Digital Health in Diabetes Care: A Narrative Review from Monitoring to the Management of Systemic and Neurologic Complications.

Journal of clinical medicine·2025
Same author

Post-COVID-19 resurgence of scabies in Campania, Italy: the hidden burden and challenges in surveillance.

Dermatology reports·2025
Same author

Facial skin rejuvenation through plasma radiofrequency ablation combined with 5% resorcinol cream: clinical and line-field confocal optical coherence tomography evaluation.

Dermatology reports·2025
Same journal

Drug-Induced Subacute Cutaneous Lupus Erythematosus Associated with Fenofibrate Lipid Lowering Agent.

Skinmed·2025
Same journal

Racial Disparities in the Management of Atopic Dermatitis: An Analysis of the National Ambulatory Medical Care Survey, 2012-2018.

Skinmed·2025
Same journal

"Pseudo-Chik Sign" Following COVID-19: Pigmentation Hitherto Unreported.

Skinmed·2025
Same journal

Hyperpigmented Scaly Lesions in the Axillae.

Skinmed·2025
Same journal

Sweet Syndrome-Like Disorder Induced by the Oxford-AstraZeneca<sup>®</sup> SARS-CoV-2 Vaccine.

Skinmed·2025
Same journal

Lockdown Lessons from Dermatology Consultations during the COVID-19 Pandemic in a Tertiary Care Center.

Skinmed·2025
See all related articles

Area of Science:

  • Dermatology
  • Immunology
  • Pharmacology

Background:

  • Toxic epidermal necrolysis (Lyell's syndrome) is a rare, severe mucocutaneous disease.
  • It is typically drug-induced, affecting the epidermis and mucosae.
  • Commonly implicated drugs include NSAIDs, chemotherapy, antibiotics, and anticonvulsants.

Purpose of the Study:

  • To review the pathophysiology and treatment of toxic epidermal necrolysis.
  • To evaluate the efficacy of various treatment modalities.
  • To highlight novel therapeutic approaches.

Main Methods:

  • Literature review of toxic epidermal necrolysis (Lyell's syndrome).
  • Analysis of drug-induced immune responses and pathogenesis.
  • Evaluation of treatment outcomes for supportive care, corticosteroids, plasmapheresis, hyperbaric oxygen, and IV immunoglobulins.

Related Experiment Videos

Main Results:

  • The condition involves acute epidermal necrosis and extensive dermoepidermal detachments.
  • Supportive care with fluids and electrolytes is crucial.
  • Systemic corticosteroids remain controversial; plasmapheresis and hyperbaric oxygen show utility.
  • High-dose intravenous immunoglobulins (IVIg) represent a promising novel treatment.

Conclusions:

  • Toxic epidermal necrolysis is a serious drug hypersensitivity reaction.
  • While supportive care is essential, IVIg offers a new, effective therapeutic option.
  • Further research into immunomodulatory treatments is warranted.